Author

P. Sanderson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Organism:non-human primate· 1 Organism:rat· 1

Frequent Co-Authors

A. Q. Wang· 1 shared C. Z. Chen· 1 shared E. C. Padilha· 1 shared M. Yang· 1 shared N. R. Hagen· 1 shared P. Shah· 1 shared P. Terse· 1 shared W. Huang· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Q. Wang

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, A Potential Oral Drug Candidate for COVID-19 Treatment

A. Q. Wang, N. R. Hagen, E. C. Padilha, M. Yang, P. Shah, C. Z. Chen, W. Huang, P. Terse, P. Sanderson, W. Zheng, X. Xu

This study examines the preclinical pharmacokinetics and in vitro ADME properties of GS-441524, showing its stability across species and varying bioavailability, supporting its development as an oral drug candidate for COVID-19.

bioRxiv · Feb 7, 2022 · PreprintPharmacology & Toxicology